ketoconazole has been researched along with dinoprostone in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Bergström, CA; Draheim, R; Holmén, AG; Wassvik, CM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Breitman, TR; Takahashi, N | 1 |
| Kufe, D; Mohri, M; Spriggs, DR | 1 |
| Bilić, A; Culo, F; Jagić, V; Rados, M; Renić, M; Sabolović, D | 1 |
| Owyang, C; Tsunoda, Y | 1 |
| Kanda, N; Watanabe, S | 2 |
| Krambovitis, E; Tsatsakis, AM; Tzanakakis, GN; Vezeridis, MP | 1 |
10 other study(ies) available for ketoconazole and dinoprostone
| Article | Year |
|---|---|
Molecular characteristics for solid-state limited solubility.
Topics: Chemical Phenomena; Chemistry, Physical; Molecular Structure; Multivariate Analysis; Pharmaceutical Preparations; Regression Analysis; Solubility | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Covalent modification of proteins by ligands of steroid hormone receptors.
Topics: Calcitriol; Dinoprostone; Electrophoresis, Gel, Two-Dimensional; Electrophoresis, Polyacrylamide Gel; Estradiol; Humans; Iodine Radioisotopes; Ketoconazole; Kinetics; Leukemia, Promyelocytic, Acute; Ligands; Molecular Weight; Neoplasm Proteins; Progesterone; Protein Binding; Receptors, Steroid; Thyroxine; Triiodothyronine; Tritium; Tumor Cells, Cultured | 1992 |
Effects of lipopolysaccharide on phospholipase A2 activity and tumor necrosis factor expression in HL-60 cells.
Topics: Acetophenones; Bucladesine; Dinoprostone; Enzyme Activation; Gene Expression; Ketoconazole; Leukocytes, Mononuclear; Lipopolysaccharides; Masoprocol; Melitten; Phospholipases; Phospholipases A; Phospholipases A2; Protein Kinase C; Quinacrine; RNA, Messenger; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1990 |
Ketoconazole inhibits acetaminophen-induced hepatotoxicity in mice.
Topics: Acetaminophen; Alanine Transaminase; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Dinoprostone; Female; Ketoconazole; Leukotriene C4; Liver; Male; Mice; Mice, Inbred CBA; Thromboxane A2 | 1995 |
A newly cloned phospholipase A2-activating protein elicits Ca2+ oscillations and pancreatic amylase secretion via mediation of G protein beta/phospholipase A2/arachidonic acid cascades.
Topics: Aminobenzoates; Amylases; Animals; Arachidonic Acids; Calcium; Chlorobenzoates; Cinnamates; Cloning, Molecular; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Activation; GTP-Binding Proteins; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Indomethacin; Ketoconazole; Kinetics; Macromolecular Substances; Male; ortho-Aminobenzoates; Pancreas; Phospholipases A; Phospholipases A2; Protein Biosynthesis; Proteins; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Time Factors | 1994 |
Ketoconazole suppresses prostaglandin E(2)-induced cyclooxygenase-2 expression in human epidermoid carcinoma A-431 cells.
Topics: Activating Transcription Factor 1; Adenylyl Cyclases; Antifungal Agents; Carcinoma, Squamous Cell; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclooxygenase 2; Dinoprostone; DNA-Binding Proteins; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; In Vitro Techniques; Isoenzymes; Ketoconazole; Membrane Proteins; Phosphorylation; Promoter Regions, Genetic; Prostaglandin-Endoperoxide Synthases; RNA, Messenger; Signal Transduction; Skin Neoplasms; Transcription Factors; Tumor Cells, Cultured | 2002 |
The preventive effect of ketoconazole on experimental metastasis from a human pancreatic carcinoma may be related to its effect on prostaglandin synthesis.
Topics: 6-Ketoprostaglandin F1 alpha; Adenocarcinoma; Animals; Antineoplastic Agents; Dinoprostone; Humans; Injections, Intraperitoneal; Ketoconazole; Liver Neoplasms; Mice; Mice, Nude; Neoplasm Metastasis; Pancreatic Neoplasms; Prostaglandin Antagonists; Prostaglandin D2; Prostaglandins; Thromboxane B2; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2002 |
Suppressive effects of antimycotics on tumor necrosis factor-alpha-induced CCL27, CCL2, and CCL5 production in human keratinocytes.
Topics: Antifungal Agents; Cells, Cultured; Chemokine CCL2; Chemokine CCL27; Chemokine CCL5; Chemokines; Chemokines, CC; Dinoprostone; Dose-Response Relationship, Drug; Gene Expression; Humans; Keratinocytes; Ketoconazole; Male; Naphthalenes; NF-kappa B; Oligonucleotides, Antisense; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP3 Subtype; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Terbinafine; Thromboxane A2; Tumor Necrosis Factor-alpha | 2006 |